Abstract
In a double-blind study with each patient as his own control, 1 g of cefazolin and 2 g of cephalothin were administered intravenously every 6 h to 20 patients in opposite arms for a period of 48 h each. The degree of phlebitis was significantly more severe with cephalothin than with cefazolin (P < 0.05); however, neither the incidence of phlebitis nor the time of onset of phlebitis was significantly different between the two drugs.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Kirby W. M., Regamey C. Pharmacokinetics of cefazolin compared with four other cephalosporins. J Infect Dis. 1973 Oct;128(Suppl):S341–S346. doi: 10.1093/infdis/128.supplement_2.s341. [DOI] [PubMed] [Google Scholar]
- Reinarz J. A., Kier C. M., Guckian J. C. Evaluation of cefazolin in the treatment of bacterial endocarditis and bacteremia. J Infect Dis. 1973 Oct;128(Suppl):S392–S396. doi: 10.1093/infdis/128.supplement_2.s392. [DOI] [PubMed] [Google Scholar]
- Ries K., Levison M. E., Kaye D. Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother. 1973 Feb;3(2):168–174. doi: 10.1128/aac.3.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turck M., Clark R. A., Beaty H. N., Holmes K. K., Karney W. W., Reller L. B. Cefazolin in the treatment of bacterial pneumonia. J Infect Dis. 1973 Oct;128(Suppl):S382–S385. doi: 10.1093/infdis/128.supplement_2.s382. [DOI] [PubMed] [Google Scholar]